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Abstract
Background: Whole-genome sequencing represents a promising approach to pinpoint chemically induced mutations in
genetic model organisms, thereby short-cutting time-consuming genetic mapping efforts.
Principal Findings: We compare here the ability of two leading high-throughput platforms for paired-end deep sequencing,
SOLiD (ABI) and Genome Analyzer (Illumina; ‘‘Solexa’’), to achieve the goal of mutant detection. As a test case we used a
mutant C. elegans strain that harbors a mutation in the lsy-12 locus which we compare to the reference wild-type genome
sequence. We analyzed the accuracy, sensitivity, and depth-coverage characteristics of the two platforms. Both platforms
were able to identify the mutation that causes the phenotype of the mutant C. elegans strain, lsy-12. Based on a 4 MB
genomic region in which individual variants were validated by Sanger sequencing, we observe tradeoffs between rates of
false positives and false negatives when using both platforms under similar coverage and mapping criteria.
Significance: In conclusion, whole-genome sequencing conducted by either platform is a viable approach for the
identification of single-nucleotide variations in the C. elegans genome.
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Introduction
Genetically amenable model organisms have been extensively
subjected to forward genetic screening approaches in which
mutant individuals that are defective in a given biological process
are isolated. Mutant isolation has traditionally been followed by
time consuming mapping procedures that localize the experimen-
tally induced region to a specific locus. We have previously shown
that sequencing with the Genome Analyzer (GA) by Illumina is
capable of identifying a molecular lesion in a C. elegans strain, lsy-
12(ot177), that results in a neuronal cell fate defect, thereby
demonstrating the utility of whole-genome sequencing as a quick
and cost-effective way to circumvent classic genetic mapping [1].
Disease-causing mutations in a human cancer patient have also
recently be reported through whole-genome sequencing [2],
illustrating the rising importance of this experimental strategy.
In an effort to better inform the design, implementation and
analysis of such genome-wide deep sequencing experiments, we
now report sequencing of the same lsy-12(ot177) mutant strain, but
now using another platform, SOLiD by ABI [3]. We compare
these parallel datasets, putting special emphasis on a 4 MB interval
around the functional mutation where we have validated the
discovered variants using lower throughput Sanger re-sequencing.
Results
We sequenced genomic DNA samples, isolated from the C. elegans
lsy-12(ot177) mutant strain [1,4], with the SOLiD and GA
platforms. Both SOLiD and GA runs provided us with similar
amounts of raw sequence. In order to separate issues directly related
to the sequencing platforms from those pertaining to mapping reads
to the genome, we used the same mapping tool, Maq [5] for both
platforms, but also used the vendor-provided alignment tool,
corona-lite by ABI (http://solidsoftwaretools.com/gf/).
Mapping of reads
Both SOLiD and GA reads were produced in paired-ends, with
SOLiD reads at a size of 25 bp and GA reads at a size of 35 bp.
Totally 146 million SOLiD reads were mapped to the wild-type
reference genome in total, representing an average depth-coverage
of 336(Table 1). Based on the library preparation protocol as well
as the mapping result, we define a pair of reads as good if the two
are mapped with correct order and orientation, and the distance
between them is less than 5000 bp for SOLiD and 500 bp for GA.
Among the mapped SOLiD reads, 82.6 million (57% of mapped)
were mapped in good pairs, and 37.3 million reads (26% of
mapped) were mapped as single ends, i.e., the other read of the
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reads were mapped to different chromosomes. In comparison,
91% of mapped GA reads were in good pairs, 2.6% in single ends,
and only 0.4% were mapped to different chromosomes. Neverthe-
less, the average coverage of good reads (defined as reads that are (a)
mapped with no more than 3 mismatches (see Methods), and (b)
either in good pairs or single ends) from both platforms are almost
identical at about 256, as summarized in Table 1.
Depth-coverage
The depth-coverage distributions of the entire genome from both
SOLiD and GA sequencing are summarized in Table 2. Both can
be modeled asGamma distributions(Figure 1)[1]. Comparedtothe
Poisson distribution with the same mean value, which was assumed
to be the model of depth coverage in some earlier studies [6], these
fitted gamma distributions have more weight on both tails.
Single Nucleotide Variants
7385 variants were called from GA, and 5798 were called from
SOLiD. We considered mapping errors and sequencing errors to
improve the accuracy of variant calling. Specifically, we only
considered variants that meet the following conditions:
1. There are at least two reads from both strands that contain the
variant allele. Any lower threshold significantly increases the
number of reported variants that are likely false positives,
without adding many true positives (see below).
2. The average number of hits per read in the position is less than
1.1. This represents a conservative cutoff to avoid repeats and
alleviate the mapping issues with the shorter SOLiD reads.
3. The depth-coverage is less than 60. That is, we filtered out
variants with .606 variants, as those are suspected to lie
within repeat regions.
4. GA reads only: The number of reads representing the wild-type
allele is less than the number of reads representing the variant
allele. This condition is based on our previous analysis
validation of the GA genome dataset [1].
After such filtering, 901 total genomic variants were left for
SOLiD and 1094 variants for GA. 685 of them were shared by both
platforms (Table 3). We previously reported that within a 4 Mb
region on chromosome V (into which the lsy-12 mutant was
mapped),GAsequencingdetected32validatedvariantsand16false-
positive variants [1] (Table 4). With the filtering criteria mentioned
above, the 16 false-positive variants were reduced to 4.However, the
filtering criteria also eliminated a true, validated variant, leaving 31
variants. SOLiD detected 23 variants, 22 of which were the same as
the previously validated ones and one was a new variant (Table 4).
This variant was also detected by GA, only with smaller coverage –
three reads from one strand and one from the other. We conducted
Sanger sequencing on this location and confirmed that this variant
(an intergenic variant at position 7953203 on chrV) is genuine.
Among the 9 confirmed variants missed by SOLiD, 5 were detected
with less than 2 reads on at least one of the strands. This reflects
insufficientdepth-coverage.Theaveragedepth-coverage at thechrV
4 Mb region approximately matches the genome-wide average from
both SOLiD and GA sequencing. However, the SOLiD reads are
shorter, so SOLiD reads covering true variants are more likely to be
rejected by the mapping process because the maximum allowed
mismatches are fixed at 3 for both SOLiD and GA (see Methods).
The depth-coverage of the variant bases from SOLiD is therefore
lower than that from GA. Two other false negatives are due to the
fact that the average number of hits of the reads covering the variant
baseislargerthan 3.0,which isa strong indicationofa multiple-copy
repeat. Another false negative was due to incorrect mapping of
SOLiD reads probably because of the way Maq treats SOLiD’s two-
color encoding. This site appears to be detectableby corona-lite with
the same filtering rules. The last false negative was missed due to
absence of reads mapping to the site. Trading off specificity for
sensitivity, i.e., requiring a single read on one strand and two on the
other, detects three additional true variants, but also 11 suspected
false positives not reported by GA.
The causal mutation in the lsy-12(ot177) strain, a G to A
nonsense mutation in the predicted gene R07B5.9 [1] was
detected by both GA and SOLiD under the filtering rules
described above (Table 3).
Table 1. Sequencing and mapping statistics.
Platform SOLiD by Maq GA by Maq SOLiD by corona-lite
Read size 25 bp 35 bp 25 bp
Total reads (million) 256 125 256
Mapped (million reads/Gb) 146/3.65 84.5/2.96 109/2.73
Good pairs (million)/percentage 41.3/57% 38.6/91% 35.5/65%
Single end mapped (million)/percentage 37.3/26% 2.23/2.6% 35.2/32.6%
Avg. depth-coverage 336 286 276
Avg. depth-coverage from good reads 256 256 NA
Mapped to different chromosomes (million)/percentage 21.9/15% 0.3/0.4% NA
doi:10.1371/journal.pone.0004012.t001
Table 2. Depth-coverage statistics.
Depth-coverage SOLiD GA
.=0 99.98% 99.96%
.=5 99.65% 99.45%
.=10 97.71% 95.83%
.=15 91.64% 86.22%
.=20 78.58% 70.85%
.=25 59.19% 52.96%
.=30 38.79% 36.18%
.=100 1.56% 0.383%
doi:10.1371/journal.pone.0004012.t002
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variants in the 4 Mb region with 42 shared. Among the shared
ones, 32 were confirmed by Sanger sequencing, 9 were left
unvalidated, and 1 was confirmed false. 8 of the unvalidated
variants and 1 confirmed false were from repeat regions, as
indicated by the average number of hits per read (.1.1). The
other unvalidated variant might be false positive because it appears
to be heterozygous. It is notable that, in total, 16 variants from GA
were confirmed to be false in our previous study, yet only one
false-positive was shared between datasets [1]. This indicates that
most of the raw variants detected by both platforms are genuine
except those in repetitive regions.
Indels
We called small insertions and deletions (indels) using Maq.
Similar to variant filtering, we discarded indels in consideration of
mappingerrorsandsequencingerrors.Wedesignedtwosetsofrules:
1. Normal filtering:
(1) coverage ,80, and
(2) number of indel reads from each strand .1.
2. Liberal filtering:
(1) coverage ,80, and
(2) number of indel reads from each strand .=1.
The result of indels is summarized in Table 5. 618 indels were
shared between normal/GA and liberal/SOLiD. If we assume
that the indels shared between two platforms are mostly genuine,
the result indicates that indels from the SOLiD sequencing are
more likely to be true and require less stringent filtering. This is
consistent with the results from our variant analysis.
From the chrV 4 Mb region, 26 indels were reported in our
previous study of the GA sequence run [1]. We get 17 of them
from SOLiD with normal filtering. With the liberal filtering rules
described above, we get 22 indels, among which 19 were validated
by manual resequencing. The remaining three were left
unvalidated.
For the GA, with the normal filtering rules described above, we
get 29 indels, 25 of which were validated by manual re-
sequencing, 4 were left unvalidated. One indel published was
missed here due to low coverage from one DNA strand. With
liberal filtering, we get all 26 confirmed indels and an additional
14 indels which were left unvalidated.
Sequencing Errors
The SOLiD technology has built-in error-detection and
correction. The corona-lite mapping tool (http://solidsoftwaretools.
com/gf/) therefore provides separate statistics regarding observed
mismatches between reads and the genome sequence. These
include 70 million automatically correctable ‘‘single’’ mismatches,
and 2.8610
6 ‘‘adjacent invalid’’ mismatches that are detectable,
even if not unambiguously correctible errors. Errors that escape
these filters make up the actual inaccuracy of the system. These,
along with genuine variants, make up the 10
6 ‘‘adjacent valid’’
mismatches. 93–97% of this group is likely due to errors, based on
two consistent estimates: The count of ‘‘adjacent invalid’’
mismatches is expected to be triple the total number of ‘‘adjacent
valid’’ mismatches due to errors; also, the estimated 10
3 genuine
variants are expected to incur 30,000–40,000 ‘‘adjacent valid’’
mismatches. These 10
6 errors among the mapped reads reflect an
error rate of 0.036%. Similarly, there are 16610
6 mismatches
reported from GA reads that were mapped in good pairs. This
represents an error rate of 0.6%.
Discussion
We compared here the performance of detecting mutations
from forward genetics by two high-throughput platforms. We were
able to find the causal mutation by both SOLiD and Solexa at
similar average coverage. The SOLiD reads are relatively shorter.
This is likely the main reason for a lower fraction of mapped reads
in good pairs, and a reason for a larger fraction of the genome
being covered by more than 1006 reads; this fraction mostly
includes regions with repeating 25-mers.
In the chrV 4 Mb region in which we had mapped lsy-12,w e
detected one new variant by SOLiD sequencing, which we
validated by Sanger sequencing. It was also present in raw Solexa
reads but was discarded due to low coverage. However, SOLiD also
missed a substantial number of validated variants that GA correctly
called. In the entire genome the number of non-repeat raw variants
detected by both SOLiD and GA is 1130 (Table 3), which is close to
the number of variants detected by either platform after filtering.
This suggests that the majority of the non-repeat variants detected
Table 3. Variants.
SOLiD GA
Common variants
(confirmed true/
confirmed false/repeats)
Raw 5798 7385 1689 (NA/NA/559)
Filtered 901 1094 685 (NA/NA/0)
ChrV 4 Mb region, raw 180 180 42 (32
{/1/9)
ChrV 4 Mb region, filtered 24 35 23 (23
{/0/0)
{Variants listed in Table 4.
doi:10.1371/journal.pone.0004012.t003
Figure 1. Distribution of depth-coverage. The distribution of
depth-coverage of the entire genome is shown for both SOLiD and GA.
Poisson and gamma distributions with comparable average mean
values are imposed on the observed distribution. Only reads that are
mapped with no more three mismatches and without inconsistent
mate-pairs are counted in the depth-coverage calculation.
doi:10.1371/journal.pone.0004012.g001
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from these two platforms are caused by different sources.
Practically, it is important to further reduce the cost of
sequencing while keep reasonable sensitivity and accuracy of
mutation detection. Given the instrument and protocol, one way
to do this is to reduce the overall depth-coverage to a minimum
level. Based on our result, having at least two reads from both
strands is a good basic measurement of variants. If we assume that
the depth-coverage follows gamma distribution, Gamma(6, C/6),
where C is the average coverage, and the sampling of two strands
follow simple Binomial distribution B(n, 0.5), then it is possible to
calculate the theoretical relationship between C and the proportion
of genomic region where at least two reads from each strand cover,
and assuming the sequencing is error-free and the genome does
not contain repeats that could hinder mapping. The result is
summarized in Figure 2. In order to achieve 95% sensitivity, 136
is required based on this calculation. Under current protocol,
roughly half a run produces 136mappable GA or SOLiD reads.
This is different from the discussion in our previous paper [1] that
took a more liberal filtering approach, that would require more
Table 4. Experimentally validated single nucleotide variants.
Position on
chromosome V
GA Variants
called in Ref. [1]
Found by
SOLiD
Why not found
by SOLiD? Type of variant
1
6302463 YES NO Repeats non-exonic
6889636 YES NO Low coverage exonic, silent
6889637 YES NO Low coverage exonic, amino-acid changing
6956711 YES NO Low coverage exonic, amino-acid changing
6956743 YES NO Low coverage exonic, amino-acid changing
6956744 YES NO Low coverage exonic, amino-acid changing
7245105 YES YES non-exonic
7377580 YES YES non-exonic
7403427 YES YES exonic, silent
7430567 YES YES exonic, amino-acid changing
7524635 YES YES non-exonic
7546600 YES YES exonic, amino-acid changing
7860248 YES NO Repeats non-exonic
7953203 NO YES non-exonic
8101405 YES NO Mapping non-exonic
8571627 YES YES exonic, amino-acid changing
8646873 YES YES non-exonic
8657771 YES YES non-exonic
8758179 YES YES exonic, amino-acid changing
9059200 YES YES non-exonic
9217870 YES YES non-exonic
9218397 YES YES non-exonic
9245971 YES YES exonic, amino-acid changing
9376379 YES YES exonic, amino-acid changing
9662867 YES NO Not covered non-exonic
9663159 YES YES non-exonic
9707449 YES YES non-exonic
9846725 (lsy-12)
2 YES YES exonic, amino-acid changing
9927293 YES YES non-exonic
9928614 YES YES exonic, silent
9986752 YES YES exonic, silent
10234234 YES YES non-exonic
10397711 YES YES non-exonic
1The nucleotide change of the variants are shown in [1]. ‘‘Non-exonic’’ is either intergenic or intronic. The one new variant identified by SOLiD is a C to T substitution.
2This is the variant that is responsible for the mutant phenotype of lsy-12 animals [1].
doi:10.1371/journal.pone.0004012.t004
Table 5. Indels.
# of indels SOLiD GA common
normal filtering 420 1280 374
liberal filtering 782 1796 663
doi:10.1371/journal.pone.0004012.t005
Whole-Genome Sequencing
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two strands and the requirement of having at least two variant-
containing reads from both strands, with very few false positives.
In conclusion, we found that SOLiD calls less false-positives
variants compared to the GA and GA calls less false-negatives
variants compared to the SOLiD. The tradeoff between tolerating
false negatives, and being able to follow up false candidates is
therefore an important determinant for platform choice (summa-
rized in Table 6). In our specific example of mutant identification
in the C. elegans genome, the experimental system allows narrowing
down the region of interest to a fraction of the genome by
traditional mapping and the system allows the following-up of
dozens of variants by various experimental strategies (including
sequencing multiple alleles, rescue analysis, RNAi analysis etc.;
[1]). A false negative, i.e. the missing of the one phenotype-causing
mutation, is not tolerable; therefore, the GA platform appears the
preferable choice for our system. Another important consideration
in choosing between the GA or SOLiD approach is the effort
required for preparing the DNA library to be sequenced. It has
been previously noted that the emulsion PCR step required for the
SOLiD platform is cumbersome and technically challenging [3],
which contrasts the apparently straight-forward library prepara-
tion step for the GA. Whatever platform one uses, it is clear that
whole-genome sequencing may revolutionize forward genetic
analysis in model organisms such as C. elegans.
We emphasize that this work represents only a snapshot-
comparison undertaken during a technological tornado. Multiple
vendors, including those discussed here, but others as well [3],
continue to push the envelope in terms of sequence accuracy,
read-length (and therefore mapping) as well as affordable
throughput. When planning future sequencing work one therefore
needs to take evidence for deficiencies in past performance with a
grain of salt. Still, as the challenges for sequencing continue to
grow hand in hand with the boundaries of feasibility, we believe
that the principles and considerations described in this manuscript
will be of use even when our exact numbers will have become
obsolete.
Materials and Methods
DNA sample preparation
Genomic DNA preparation: Genomic C. elegans DNA was
prepared using a modified protocol obtained from the Compre-
hensive Protocol Collection at Dartmouth University (http://www.
dartmouth.edu/,ambros/protocols/MGH_protocols/Worm_
genomic_DNA.html). Forty 5-cm plates of lsy-12 mutants worms
were used. DNA concentrations were estimated using agarose gel
electrophoresis. 5 mg were provided to Illumina’s sequencing
service, as previously reported [1] and 100 mgw e r ep r o v i d e dt o
Agencourt, who performed the ABISolid runs.
DNA Sequencing
Sequencing runs were performed by Agencourt Bioscience
Corporation (a Beckman Coulter Company) for the ABI Solid
runs and by Illumina’s in-house sequencing services for the GA
sequence run, as described in [1].
Bioinformatic analysis
All reads were mapped using Maq. The maximum allowed
number of mismatches per read was 3 for both platforms. This
cutoff was selected to accommodate both mismatches due to true
variants, as well as ones due to errors that at are rare per bp, but
Figure 2. The relationship between average depth-coverage and variant detection sensitivity. The x-axis is the average depth-coverage.
The y-axis is the theoretical fraction of genome where potential variants can be detected under the assumptions described above. The red dot marks
95% sensitivity at 136coverage.
doi:10.1371/journal.pone.0004012.g002
Table 6. Comparing platforms.
Feature Preferred Platform
Reducing false positives SOLiD
Reducing false negatives GA
Raw accuracy SOLiD
Mapping GA
Ease of library preparation GA
doi:10.1371/journal.pone.0004012.t006
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correct read pair was set to 5000 for SOLiD and 250 for GA.
Other parameters were default. The SOLiD reads were treated
slightly different than GA reads in Maq: the -p in pileup function is
supposed to output only the read pairs that are regarded as good,
but none of the SOLiD pairs are regarded good because SOLiD
reads are always FF or RR oriented, whereas only FR reads are
regarded as good reads – based on the man page on mapview
function. So we took all good paired SOLiD reads as well as single-
end mapped reads and re-mapped them using Maq. As for GA
reads, we output pileup using -p option. Thus the only difference is
the single-ended reads are discarded in GA pileup, which would
not have much impact on the variant and coverage analysis
because they only contributed 2.6% to all mapped GA reads.
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